 Sulfonylureas ATP-sensitive K+ channels cellular K+ loss hypoxia ischemia metabolic inhibition mammalian ventricle Sulfonylurea derivatives selective blockers ATP-sensitive K+ KATP channels ability cellular K+ loss shortening action potential duration ischemia hypoxia intact heart modest efficacy KATP channels excised membrane patches isolated perfused rabbit interventricular septum increase unidirectional K+ efflux shortening action potential duration substrate-free hypoxia glibenclamide high concentrations microM hypoxia glucose present glibenclamide effective K+ loss total global ischemia minutes microM glibenclamide mM shortening action potential duration K+ accumulation maximum isolated patch-clamped guinea pig ventricular myocytes whole-cell ATP-sensitive K+ current exposure metabolic inhibitors glibenclamide microM tolbutamide mM effective whole-cell ATP-sensitive K+ current maximum block ADP patch electrode solution inside-out membrane patches myocytes glibenclamide unitary currents KATP channels Kd microM Hill coefficient absence ADP cytosolic membrane surface block incomplete microM ADP free present ADP similar effect block KATP channels tolbutamide findings free cytosolic ADP microM range early myocardial ischemia hypoxia limited efficacy sulfonylureas ischemic hypoxic cellular K+ loss conditions